Debrisoquine oxidation phenotype and susceptibility to lung cancer.
about
Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancerAdvances in mechanisms of activation and deactivation of environmental chemicalsAssociation between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer.Genetic aspects of drug disposition and therapeutics.The human hepatic cytochromes P450 involved in drug metabolism.Clinical consequences of polymorphic drug oxidation.Genetic differences in drug disposition.Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite.Cancer risk related to genetic polymorphisms in carcinogen metabolism and DNA repair.The rationale for case-control methodology in epidemiological studies of cancer risk (response to Speirs et al., 1990)Screening, Early Detection, and Early Intervention Strategies for Lung Cancer.The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.
P2860
Q34358477-32437454-EE68-4DA1-B95D-8144850E0680Q34843567-EBE6FDF8-4845-4F27-ACAD-F8EA3C55B44DQ35938660-3E0E86EA-FDEB-45CA-A82D-2CAF8AB4F6D8Q36244452-E45C1356-CB19-4DF3-A82C-7F41DB05D77EQ36258518-F30A96D0-15AF-4918-AC4F-DB16C4EFAD45Q37448263-BBE18098-5F6B-445A-9CBD-0EC64F2AF456Q40645305-20AE1574-B2A4-431D-A21B-98105CA5FFF4Q40700833-AF55854E-BD21-4172-8E5D-4FED3F81FA72Q40897262-14263AEB-8184-44A2-B6DD-F90BFA5862EDQ41871756-D284D2F2-2045-44BE-BDCD-4D2E3275CA51Q51119986-2A88DB16-6A9E-42A3-AE1D-B09973B9F5D9Q52892865-BCD61764-C672-4A8C-AA75-087E2EECB1BE
P2860
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@ast
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@en
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@nl
type
label
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@ast
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@en
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@nl
prefLabel
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@ast
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@en
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@nl
P2093
P2860
P1476
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
@en
P2093
A F Biola Mabadeje
A R Boobis
C J Speirs
D S Davies
P2860
P304
P356
10.1111/J.1365-2125.1990.TB03608.X
P407
P577
1990-01-01T00:00:00Z